HIGHLAND CAPITAL MANAGEMENT LP - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 175 filers reported holding IMMUNOMEDICS INC in Q1 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
HIGHLAND CAPITAL MANAGEMENT LP ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q1 2019$480,000
+31.5%
25,0000.0%0.03%
+57.9%
Q1 2018$365,000
-67.8%
25,000
-64.3%
0.02%
-63.5%
Q4 2017$1,132,000
+101.4%
70,000
-49.4%
0.05%
+372.7%
Q2 2015$562,000
-57.6%
138,400
-60.0%
0.01%
-59.3%
Q1 2015$1,325,000346,0900.03%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,711,067$2,943,0001.70%
J.P. Turner & Co Capital Mnagement, LLC 248,625$428,0000.44%
Orbimed Advisors 3,323,000$5,716,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 2,004,078$3,447,0000.02%
WOLVERINE ASSET MANAGEMENT LLC 5,870$1,018,0000.02%
SIGNET FINANCIAL MANAGEMENT, LLC 44,675$77,0000.02%
SVB WEALTH LLC 195,000$335,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 288,900$497,0000.01%
J.P. Turner & Co Capital Mnagement, LLC 153,900$8,0000.01%
NEXT Financial Group, Inc 13,000$22,0000.01%
View complete list of IMMUNOMEDICS INC shareholders